UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predicting the Effect of Amino Acid Single-Point Mutations on Protein Stability—Large-Scale Validation of MD-Based Relative Free Energy Calculations

Journal of molecular biology, 2017-04, Vol.429 (7), p.948-963

2017

Volltextzugriff (PDF)

Generation of specific inhibitors of SUMO-1- and SUMO-2/3-mediated protein-protein interactions using Affimer (Adhiron) technology

Science signaling, 2017-11, Vol.10 (505)

2017

Volltextzugriff (PDF)

The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer

Frontiers in oncology, 2022-07, Vol.12, p.885139-885139

2022

Volltextzugriff (PDF)

Effect of Zn2+ on DNA Recognition and Stability of the p53 DNA-Binding Domain

Biochemistry (Easton), 2006-06, Vol.45 (24), p.7483-7492

2006

Volltextzugriff (PDF)

Improving the Accuracy of Protein Thermostability Predictions for Single Point Mutations

Biophysical journal, 2020-07, Vol.119 (1), p.115-127

2020

Volltextzugriff (PDF)

Identification of Human Intestinal Alkaline Sphingomyelinase as a Novel Ecto-enzyme Related to the Nucleotide Phosphodiesterase Family

The Journal of biological chemistry, 2003-10, Vol.278 (40), p.38528-38536

2003

Volltextzugriff (PDF)

Understanding the Molecular Activity of Alkaline Sphingomyelinase (NPP7) by Computer Modeling

Biochemistry (Easton), 2010-10, Vol.49 (42), p.9096-9105

2010

Volltextzugriff (PDF)

A novel class of tubulin inhibitors that exhibit potent antiproliferation and in vitro vessel-disrupting activity

Cancer chemotherapy and pharmacology, 2008-05, Vol.61 (6), p.953-963

2008

Volltextzugriff (PDF)

Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods

Journal of molecular graphics & modelling, 2010-09, Vol.29 (2), p.157-170

2010

Volltextzugriff (PDF)

Enhanced pharmacological activities of AKR1C3-activated prodrug AST-3424 in cancer cells with defective DNA repair

International journal of cancer, 2024-09

2024

Volltextzugriff (PDF)

Bond durability of BFRP and GFRP bars in sulphoaluminate cement concrete under water immersion environment

Construction & building materials, 2024-06, Vol.432, p.136521, Article 136521

2024

Volltextzugriff (PDF)

A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation

Immunity (Cambridge, Mass.), 2019-04, Vol.50 (4), p.1043-1053.e5

2019

Volltextzugriff (PDF)

AutoQSAR: an automated machine learning tool for best-practice quantitative structure-activity relationship modeling

Future medicinal chemistry, 2016-10, Vol.8 (15), p.1825-1839

2016

Volltextzugriff (PDF)

Safety, tolerability, pharmacokinetics and clinical activity of AST-3424, an AKR1C3-activated bis-alkylating moiety prodrug, in subjects with advanced solid tumors in China: A phase I dose-escalation study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3121-3121

2024

Volltextzugriff (PDF)

Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling

Journal of computer-aided molecular design, 2015-02, Vol.29 (2), p.165-182

2015

Volltextzugriff (PDF)

Research Progresses on Surface Modification of Nanomaterials and Anti-Corrosion Performance of Corresponding Modified Epoxy Coatings

Cai liao bao hu, 2022-12, Vol.55 (12), p.156-165

YAN Dong, ZHONG Ping, YUAN Jianxin, DUAN Jindi, DENG Jiyong

2022

Volltextzugriff (PDF)

Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells

Nature (London), 2023-09, Vol.621 (7980), p.840-848

2023

Volltextzugriff (PDF)

Abstract 1220: Selective and broad anti-tumor activity of AKR1C3-activated prodrug AST-3424/OBI-3424

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1220-1220

2021

Volltextzugriff (PDF)

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

Clinical cancer research, 2019-07, Vol.25 (14), p.4493-4503

2019

Volltextzugriff (PDF)

Robust Prediction of Relative Binding Energies for Protein–Protein Complex Mutations Using Free Energy Perturbation Calculations

Journal of molecular biology, 2024-08, Vol.436 (16), p.168640, Article 168640

2024

Volltextzugriff (PDF)

Improving the Transmission Rate by A Two-Phase Hybrid Duplex Scheme for Gaussian Relay Channel

ICC 2024 - IEEE International Conference on Communications, 2024, p.4233-4238

2024

Volltextzugriff (PDF)

TH‐302: A Highly Selective Hypoxia‐Activated Prodrug for Treating PARP Inhibitor–Resistant Cancers

Journal of clinical pharmacy and therapeutics, 2024-01, Vol.2024 (1)

2024

Volltextzugriff (PDF)

39.2: Invited Paper: First, Faster, Further: Competitive Advantage with Next‐Generation Materials Development

SID International Symposium Digest of technical papers, 2023-04, Vol.54 (S1), p.254-257

2023

Volltextzugriff (PDF)

A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity

American journal of cancer research, 2023-11, Vol.13 (11), p.5750-5750

2023

Volltextzugriff (PDF)

Erratum: A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity

American journal of cancer research, 2023-01, Vol.13 (11), p.5750-5750

2023

Volltextzugriff (PDF)

1 – 25 von 620

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(539)
Mit Volltextzugriff
(549)

Publikationsform

Sprache

Englisch
(610)
Chinesisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(466)
Life Sciences & Biomedicine
(242)
Technology
(166)
Physical Sciences
(145)
Humans
(113)
Chemistry
(83)
Materials Science
(83)
Biochemistry & Molecular Biology
(70)
Animals
(56)
Materials Science, Multidisciplinary
(54)
Engineering
(46)
Computer Science
(45)
Science & Technology - Other Topics
(44)
Female
(43)
Male
(43)
Proteins
(34)
Physics
(33)
Chemistry, Physical
(30)
Algorithms
(29)
Gene Expression
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(20)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Predicting the Effect of Amino Acid Single-Point Mutations on Protein Stability—Large-Scale Validation of MD-Based Relative Free Energy Calculations

Generation of specific inhibitors of SUMO-1- and SUMO-2/3-mediated protein-protein interactions using Affimer (Adhiron) technology

The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer

Effect of Zn2+ on DNA Recognition and Stability of the p53 DNA-Binding Domain

Improving the Accuracy of Protein Thermostability Predictions for Single Point Mutations

Identification of Human Intestinal Alkaline Sphingomyelinase as a Novel Ecto-enzyme Related to the Nucleotide Phosphodiesterase Family

Understanding the Molecular Activity of Alkaline Sphingomyelinase (NPP7) by Computer Modeling

A novel class of tubulin inhibitors that exhibit potent antiproliferation and in vitro vessel-disrupting activity

Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods

Enhanced pharmacological activities of AKR1C3-activated prodrug AST-3424 in cancer cells with defective DNA repair

Bond durability of BFRP and GFRP bars in sulphoaluminate cement concrete under water immersion environment

A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation

AutoQSAR: an automated machine learning tool for best-practice quantitative structure-activity relationship modeling

Safety, tolerability, pharmacokinetics and clinical activity of AST-3424, an AKR1C3-activated bis-alkylating moiety prodrug, in subjects with advanced solid tumors in China: A phase I dose-escalation study

Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling

Research Progresses on Surface Modification of Nanomaterials and Anti-Corrosion Performance of Corresponding Modified Epoxy Coatings

Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells

Abstract 1220: Selective and broad anti-tumor activity of AKR1C3-activated prodrug AST-3424/OBI-3424

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

Robust Prediction of Relative Binding Energies for Protein–Protein Complex Mutations Using Free Energy Perturbation Calculations

Improving the Transmission Rate by A Two-Phase Hybrid Duplex Scheme for Gaussian Relay Channel

TH‐302: A Highly Selective Hypoxia‐Activated Prodrug for Treating PARP Inhibitor–Resistant Cancers

39.2: Invited Paper: First, Faster, Further: Competitive Advantage with Next‐Generation Materials Development

A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity

Erratum: A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity

Suchergebnisse filtern